Grazie alla ricerca pluriennale condotta con l'Università di Bologna, abbiamo sviluppato la linea di buffer/reagenti DoMo Genetics per biologia molecolare, per una diagnosi oncologica veloce ed affidabile.
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 28, 2023 | 20 scale-ups selected for EIT Health Bridgehead 2023 | We are delighted to announce that we have selected twenty healthcare scale-ups to receive customised assistance to expand their businesses internationally through our Bridgehead programme in 2023. Our selected scale-ups represent a diverse ... |
| Apr 3, 2023 | Startup Showcase: OaCP – Revolutionizing Cancer Diagnosis with CE-IVD Chemical Reagents | OaCP is a groundbreaking startup based in Cork, Cork, Ireland that is revolutionizing the way cancer is diagnosed. With patented and CE-IVD chemical reagents, the company is able to reduce the time and cost of DNA tests for cancer diagnosis... |
| Aug 25, 2022 | TechChill Milano Startup Pitch Battle semi-finalists | The first Southern European startup entrepreneurship event TechChill Milano will take place on September 27th-29th in Milan to further put Italy on the global startup map and bring together international industry experts and brightest talen... |
Reviews 0
FAQ about OaCP
When was OaCP founded?
OaCP was founded in 2017.
What has the press written about OaCP?
Parsers VC has collected 4 articles mentioning OaCP, among them “20 scale-ups selected for EIT Health Bridgehead 2023” (Jul 28, 2023) and “Startup Showcase: OaCP – Revolutionizing Cancer Diagnosis with CE-IVD Chemical Reagents” (Apr 3, 2023).
Is OaCP still active?
Yes, OaCP is active; its latest activity on Parsers VC dates from Sep 27, 2023.